NCT03757299View on ClinicalTrials.gov

Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon

NACompletedINTERVENTIONAL
Enrollment

4,473

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 5, 2022

Study Completion Date

July 9, 2024

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

HPV Test

Vaginal specimens for HPV test will be collected by participants themselves using flocked swabs after explanations by co-investigators. Two transport mediums will be used for those self-collected vaginal samples: NaCl 0.9%.

Trial Locations (1)

1205

University of Geneva, Geneva

All Listed Sponsors
lead

Prof. Patrick Petignat

OTHER

NCT03757299 - Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon | Biotech Hunter | Biotech Hunter